The Italian drug givinostat has won the Prix Galien for its ability to slow the progression of Duchenne muscular dystrophy, offering new therapeutic opportunities for a large population of patients. #DistrofiaDiDuchenne #MalattieRare #InnovazioneMedica (translated)
